The company uses a stereolithography-based bioprinting technology to create complex 3D structures made of biopolymers. They offer tailor-made products for individual customer specifications, such as mini-organs for drug testing, tissues for regenerative medicine, and scaffolds for growing cells in 3D cultures. Cellbricks combines expertise in synthetic biology and 3D bioprinting to replicate human tissue at scale, with the goal of improving clinical treatments. Their team consists of biotech enthusiasts, scientists, PhDs, engineers, chemists, and entrepreneurs from top universities and companies worldwide, and they are located in Berlin, Europe's start-up capital.